Meyer-Schwickerath R - Search Results

1

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Lösche C, Röllmann R, Schatz H. Meyer-Schwickerath R, et al. J Clin Invest. 1993 Dec;92(6):2620-5. doi: 10.1172/JCI116877. J Clin Invest. 1993. PMID: 7504689 Free PMC article.

2

Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.

Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A. Spranger J, et al. Exp Clin Endocrinol Diabetes. 1999;107(1):21-8. doi: 10.1055/s-0029-1212068. Exp Clin Endocrinol Diabetes. 1999. PMID: 10077351

3

[TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].

Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A. Spranger J, et al. Med Klin (Munich). 1995 Mar 1;90(3):134-7. Med Klin (Munich). 1995. PMID: 7723714 German.

4

Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.

Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Pfeiffer A, et al. Diabetes. 1997 Sep;46 Suppl 2:S26-30. doi: 10.2337/diab.46.2.s26. Diabetes. 1997. PMID: 9285495 Review.

5

Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.

Spranger J, Bühnen J, Jansen V, Krieg M, Meyer-Schwickerath R, Blum WF, Schatz H, Pfeiffer AF. Spranger J, et al. Among authors: meyer schwickerath r. Horm Metab Res. 2000 May;32(5):196-200. doi: 10.1055/s-2007-978621. Horm Metab Res. 2000. PMID: 10871161

6

[Development of neovascularization of the optic papilla, retina and iris. Dependence on site and extent of retinal ischemia].

Nahberger D, Meyer-Schwickerath R, Saygili O, Gronemeyer U. Nahberger D, et al. Among authors: meyer schwickerath r. Ophthalmologe. 2000 Jun;97(6):422-8. doi: 10.1007/s003470070092. Ophthalmologe. 2000. PMID: 10916386 German.

7

Insulin, insulin analogues and diabetic retinopathy.

Chantelau E, Kimmerle R, Meyer-Schwickerath R. Chantelau E, et al. Among authors: meyer schwickerath r. Arch Physiol Biochem. 2008 Feb;114(1):54-62. doi: 10.1080/13813450801900553. Arch Physiol Biochem. 2008. PMID: 18465359 Review.

8

Central retinal venous outflow pressure.

Meyer-Schwickerath R, Kleinwächter T, Firsching R, Papenfuss HD. Meyer-Schwickerath R, et al. Graefes Arch Clin Exp Ophthalmol. 1995 Dec;233(12):783-8. doi: 10.1007/BF00184090. Graefes Arch Clin Exp Ophthalmol. 1995. PMID: 8626087

9

[Ischemic or non-ischemic central artery occlusion. An explanation for the development or lack of development of neovascularization].

Meyer-Schwickerath R, Hagel A, Nahberger D, Gronemeyer U. Meyer-Schwickerath R, et al. Ophthalmologe. 1994 Jun;91(3):293-7. Ophthalmologe. 1994. PMID: 7522065 German.

10

Downregulation of serum IGF-1 for treatment of early worsening of diabetic retinopathy: a long-term follow-up of two cases.

Chantelau E, Meyer-Schwickerath R, Klabe K. Chantelau E, et al. Among authors: meyer schwickerath r. Ophthalmologica. 2010;224(4):243-6. doi: 10.1159/000260231. Epub 2009 Nov 24. Ophthalmologica. 2010. PMID: 19940532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters